Screener
Jazz Pharmaceuticals JAZZ Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's invested capital?
- Jazz Pharmaceuticals (JAZZ) reported invested capital of $9.27B in Q1 2026.
- How has Jazz Pharmaceuticals's invested capital changed year-over-year?
- Jazz Pharmaceuticals's invested capital increased by 20.0% year-over-year, from $7.72B to $9.27B.
- What is the long-term trend for Jazz Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's invested capital has grown at a 13.3% compound annual growth rate (CAGR), from $4.85B to $9.06B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Jazz Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude